Duke in the news!

From the Health Blog over at the Wall Street Journal:

Duke University Medical Center and the FDA are set to launch a partnership to try to improve the nation’s clunky clinical-trials process.

A recent report from the inspector general of the FDA’s parent agency, the Department of Health and Human Services, estimated that the agency inspects only around one percent of clinical trial sites. The FDA also struggles to track trials, and its “guidance and regulations don’t reflect current clinical trials practices” the report says.

Click here to access (sub. req.)